- Associated Press•7 hours ago
U.S. regulators on Tuesday approved the first lower-cost version of Enbrel, a blockbuster anti-inflammatory drug from Amgen that is among the top-selling drugs in the world.
- Market Realist•7 hours ago
StrataGraft, if approved, will be the first biological off-the-shelf skin substitute for treating severe burns.
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
|Day's Range||34.85 - 35.18|
|52wk Range||28.25 - 37.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||30.92|
|Avg Vol (3m)||21,811,533|
|Dividend & Yield||1.20 (3.45%)|